Metastasis Contain the Loss of Heterozygosity Events Impeding Breast Cancer

Abstract

Breast cancer mortality is seldom attributable to the primary tumor, but rather to the presence of systemic (metastatic) disease. Axillary lymph node dissection can identify the presence of metastatic breast cancer cells and serves as a marker for systemic disease. Previous work in our laboratory determined that rates of loss of heterozygosity (LOH) of a 1… (More)

Topics

3 Figures and Tables

Cite this paper

@inproceedings{Martin2001MetastasisCT, title={Metastasis Contain the Loss of Heterozygosity Events Impeding Breast Cancer}, author={Michelle D. Martin and Kathy Fischbach and C. Kent Osborne and S. Mohsin and D. Craig. Allred and Peter O’Connell}, year={2001} }